Summary
The two-period crossover trial has the evident advantage that by the use of within-patients comparisons, the usually larger between-patient variability is not used as a measuring stick to compare treatments. However, a prerequisite is that the order of the treatments does not substantially influence the outcome of the treatment. Crossover studies with a binary response (such as yes/no or present/absent), although widely used for initial screening of new compounds, have not previously been studied for such order effects. In the present paper we use a mathematical model based on standard statistical tests to study to what extent such order effects, here identical to carryover effects, may reduce the power of detecting a treatment effect. We come to the conclusion that in spite of large carryover effects the crossover study with a binary response remains a powerful method and that testing for carryover effects makes sense only if the null hypothesis of no treatment effect cannot be rejected.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
8. References
Cleophas TJM: A simple analysis of carryover studies with one-group interaction. Int J Clin Pharmacol Ther 1995; 32: 322–328.
Cleophas TJ: Underestimation of treatment effect in crossover trials. Angiology 1990;41:855–864.
Brown BW: The crossover experiment for clinical trials. Biomerrics 1980;36:69–79
Barker M, Hew RJ, Huitson A, Poloniecki J: The two-period crossover trial. Bias 1982; 9: 67–112.
Louis TA, Lavori PW, Bailar JC, Polansky M: Crossover and self-controlled design in clinical research. N Engl J Med 1984; 310: 24–31.
Willan AR, Pater JL: Carryover and the two-period clinical trial. Biometrics 1986;42:593–599.
Packer M: Combined beta-adrenergic and calcium entry blockade in angina pectoris. N Engl J Med 1989; 320: 709–718.
Fleiss JL: A critique of recent research on the two-treatment crossover design. Control Clin Trials 1989; 10: 237–243.
Freeman PR: The performance of the two-stage analysis of two-treatment, two-period crossover trials. Stat Med 1989; 8: 1421–1432.
Senn S. Crossover trials in clinical research. Wiley & Sons, Chicester, 1993.
Hills M. Armitage P: The two-period crossover trial. Br J Clin Pharmacol 1979; 8: 7–20.
Gart JJ: An exact test for comparing matched proportions in crossover designs. Biometrika 1969; 56: 57–80.
Prescott RJ: The comparison of success rates in crossover trials in the presence of an order effect. Appl Stat 1981; 30: 9–15.
Fidler V: Change-over clinical trials with binary data: mixed model-based comparisons of tests. Biometrics 1984; 40: 1063–1079.
Bavry JH: Design Power (TM). Scientific software Inc., 1988, Hillsdale, New Jersey.
Cleophas TJM, Tavenier P. Clinical trials of chronic diseases. J Clin Pharmacol 1995; 35: 594–598.
Cleophas TJM, Tavenier P. Fundamental issues of choosing the right type of trial. Am J Ther 1994; 1: 327–332.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Cleophas, T.J., Zwinderman, A.H., Cleophas, T.F. (2002). Crossover Studies with Binary Responses. In: Statistics Applied to Clinical Trials. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0337-7_13
Download citation
DOI: https://doi.org/10.1007/978-94-010-0337-7_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-0570-1
Online ISBN: 978-94-010-0337-7
eBook Packages: Springer Book Archive